Dr. Rosalia Emma will discuss the presentation “Inhalation preclinical assessment: In vitro science for real life user” during the panel dedicated to “Tackling concerns around industry standards”.
"From biologic mechanisms to theragnostic paths in the Hereditary Cancer Syndromes: germline mutations as a therapeutic target" is the title of the meeting held at the Temple University, Friday, May 12. Although hereditary cancer…
According to Prof. Polosa: “The study does not present any causality between data and the hypothesis according to which there would be health complications for vapers”, In fact, as the scientist explains: “The very small sample size and low reproducibility of the tests does not allow us to give a precise and scientific answer on pulmonary inflammation caused by vaping because it does not take into consideration fundamental factors, such as the prior exposure to tobacco smoking”.
The European Commission has launched a public consultation on the "Evaluation of the legislative framework for tobacco control" which allows citizens, experts, industries and all stakeholders to express their opinion on the revision of the Tobacco Directive (TPD) through filling in a multiple-choice questionnaire, and sharing a final opinion of up to 500 characters.
To present the latest news regarding harm reduction strategies in the prevention of bone diseases, prof. Riccardo Polosa, Founder of the CoEHAR, and prof. Giovanni Li Volti, Director of the center, will attend the 2023 edition of the IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases from May 4 to May 7 in Barcelona
Today, Tuesday May 09, the University of Kragujevac in collaboration with the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) University of Catania (Italy) has organized in Serbia a Scientific…
A group of researchers from the CoEHAR of the University of Catania, led by prof. Pasquale Caponnetto, conducted a systematic review that analyzed the main and most recent forms of…
On May 2, prof. Massimo Caruso, CoPI of the Replica project, held a seminar at the Temple University, Sbarro Institute, titled "The "REPLICA" project: addressing the replication crisis in tobacco harm reduction studies".
Researchers from CoEHAR's In Silico Science project have developed a two-step technique to identify spin bias, research reporting that results in an intentional or unintentional misinterpretation of research results.
One of the speakers of the event, moderated by Prof. Carla Bruschelli, was Prof. Riccardo Polosa, founder of CoEHAR, Center of Excellence for the acceleration of Harm Reduction, and professor of Internal Medicine at the University of Catania. The subject of his speech was the patient with COPD (Chronic Obstructive Pulmonary Disease) with addiction to smoking, which he defined as "a difficult patient, because he has a long history that has created a strong alliance with cigarettes. Therefore, giving up smoking leads him to a great form of distress, because it represents a loss”.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.